Robert "Bob" Cooper of the L.A. firm Gibson Dunn defended some of the country’s largest and most recognizable companies from ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

Activist investor Starboard Value disclosed a 9% stake in Tripadvisor on Thursday, and said the stock was "undervalued".

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Pfizer Inc. (NYSE:PFE) ranks among the best set-it-and-forget-it stocks to buy. On June 26, Pfizer Inc. (NYSE:PFE) declared ...

In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the ...

I didn’t set out to build a global innovation network spanning 45 countries. Here are four lessons from my journey.

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is considering delisting its UK stock market listing for the US.

With the largest defense budget in the world, the United States spares no expense to make sure it has the largest military ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...